Share. Never miss a …
Laurus Labs Q1 Results 2020-21: Net profit jumped 1,047% year-on-year to Rs 172 crore on the back of revenue that rose 77% to Rs 974 crore.
Custom Synthesis business has maintained its growth trajectory with strong contribution from all the divisional segments. Quarterly Results of Laurus Labs (in Rs. Despite the challenges posed by COVID-19 we have clocked a revenue growth of 77% in the quarter. Laurus Labs - Unaudited Financial Results For The Quarter Ended June 30, 2020 29th-Jul-2020 16:11 Source: BSE Laurus Labs - Disclosures under Reg. Research & Development (R&D) spent Rs 42 crore, which is 4.3% of sales in Q1 FY21.Commenting on the Q1 result, Dr Satyanarayana Chava, the founder and chief executive officer (CEO) of Laurus Labs, has said that: "I am very happy to share that we have started the new Financial year on a very strong note. In the other API segment, contract manufacturing of Generic APIs showing robust growth of more than 2 times.
The Other API business segment continues to post healthy growth with improved volumes. Revenues from operations were up 77 per cent during the quarter under discussion to Rs 974 crore, a press release said. 30 LakhCheck Personal Loan Interest Rates Of Top 10 Banks On Rs. 1 Lakh LoanHome Loan Conversion vs. Balance Transfer: How to Decide?Gold Prices In India Could Touch Rs 70,000: ICICI Direct laurus labs ltd q2 results Blogs, Comments and Archive News on Economictimes.com For the April-June, 2020 quarter, Laurus Labs posted consolidated revenue of Rs 974 crore, up 77 per cent year-on
Laurus Labs Standalone Quarterly Results The company filed 262 patent applications and 121 patent granted as on 30 June 2020.Meanwhile, the board has fixed 30 September 2020 as the record date for 5-for-1 stock split.Laurus Labs researches, develops, and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The drug maker serves customers worldwide.Zydus Cadila launches Remdesivir injection at Rs 2,800Bollywood Actress and TV Host Mandira Bedi Buys Herself a Tata Nexon EV Electric SUVPlanning To Take A Personal Loan? The pharmaceutical company's consolidated net profit surged 1,037.61% to Rs 171.78 crore on 76.96% spurt in revenue from operations to EBITDA margin for the quarter stood at 29%.
The pharmaceutical company's consolidated net profit surged 1,037.61% to Rs 171.78 crore on 76.96% spurt in revenue from operations to Rs 974.32 crore in Q1 June 2020 over Q1 June 2019. Our Anti-Viral API portfolio has showcased a strong revenue growth of 19% on the back of higher volumes and offtake in EFV & TDF along with launch of DTG to Third Parties. Our EBITDA has grown over 2 times and our profitability also improved significantly to Rs 172 crore. Chava is confident of maintaining this kind of margin and EBITDA. The Anti-Viral segment showed growth of 19% and is expected to have growth for the full year. Choose your winners rationally in 3 simple steps!Choose your reason below and click on the Report button.
Consolidated profit before tax (PBT) soared 1,042.18% to Rs 221.47 crore in Q1 June 2020 as against Rs 19.39 crore in Q1 June 2019.
Laurus Labs shares closed at 790.25 on July 30, 2020 (NSE) and has given 81.40% returns over the last 6 months and 132.26% over the last 12 months. Wait and watch. Reproduction of news articles, photos, videos or any other content in whole or in part in any form
It was Rs 551 crore in the first quarter of the last fiscal.
Read more about Laurus Labs reports stellar Q1 results on Business Standard. Read more about Laurus Labs reports stellar Q1 results on Business Standard.
Why follow tips? This will alert our moderators to take actionLaurus Labs Q1 results: Net profit up 11 times to Rs 172 croreCopyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. Read more about Laurus Labs in focus, zooms over 15%; stock hits all-time high on Business Standard.
Hyderabad - Laurus Labs Ltd. (Laurus BSE: 540222, NSE: LAURUSLABS, ISIN: INE947Q01010), a leading research and development driven pharmaceutical company in India announcesits Q1 FY20 results.
Laurus Labs Limited's net profit for the quarter ended June 30 increased over 11 times to Rs 172 crore against Rs 15 crore during the same period in FY20, the company said. Rupee value growth can be achieved with price increase also in the short term..not sustainable though.Post IPO flushed with capital, companies used to show good results for 4-5 Quarters then on SLUMP to rock bottom.. Current tax expense for the quarter surged 1,098.24% at Rs 54.76 crore as against Rs 4.57 crore in Q1 June 2019. Copyright © e-Eighteen.com Ltd. All rights reserved. Share. Reblog.